Loading
Life sciences · Journal article
npj Drug Discovery. · September 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Precision medicine selects individual treatments from a small toolbox of therapies already available. Personalized drug discovery (PDD) brings this concept one step ahead, developing drugs for individual patient’s diseases. Currently, PDD is being developed for rare disorders, where conventional drug discovery paradigms are non-applicable due to small patient sizes, but also for cancer. As a new frontier in precision medicine, PDD should be upscaled in rare and non-rare diseases.